| 701 |
17702855 | Serum proprotein convertase subtilisin kexin type 9 is correlated directly with serum LDL cholesterol. | 2007 Oct |
6 |
| 702 |
17940607 | Proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke. | 2007 Oct 17 |
2 |
| 703 |
17993811 | New targets and emerging therapies for reducing LDL cholesterol. | 2007 Dec |
1 |
| 704 |
18006936 | Sequence variation in proprotein convertase subtilisin/kexin type 9 serine protease gene, low LDL cholesterol, and cancer incidence. | 2007 Nov |
2 |
| 705 |
16424354 | Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy. | 2006 May |
1 |
| 706 |
16554528 | Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. | 2006 Mar 23 |
2 |
| 707 |
16619215 | The c.43_44insCTG variation in PCSK9 is associated with low plasma LDL-cholesterol in a Caucasian population. | 2006 May |
2 |
| 708 |
16987874 | Genetic susceptibility to myocardial infarction and coronary artery disease. | 2006 Oct 15 |
2 |
| 709 |
17051583 | Proapoptotic effects of NARC 1 (= PCSK9), the gene encoding a novel serine proteinase. | 2006 Nov 1 |
2 |
| 710 |
17080197 | Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. | 2006 Nov |
1 |
| 711 |
17101087 | [PCSK9, from gene to protein: a new actor involved in cholesterol homeostasis]. | 2006 Nov |
1 |
| 712 |
17142622 | Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. | 2006 Dec |
2 |
| 713 |
15677715 | Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. | 2005 Feb 8 |
2 |
| 714 |
15767856 | Proprotein convertase subtilisin kexin 9: the third locus implicated in autosomal dominant hypercholesterolemia. | 2005 Apr |
4 |
| 715 |
16080633 | The diagnosis and management of familial hypercholesterolaemia. | 2005 May-Jun |
2 |
| 716 |
14727156 | Genetic variants in PCSK9 affect the cholesterol level in Japanese. | 2004 |
2 |
| 717 |
15099351 | Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia. | 2004 May |
3 |
| 718 |
15166014 | Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9. | 2004 Aug |
1 |
| 719 |
15178557 | Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia. | 2004 Aug |
2 |
| 720 |
15358785 | NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. | 2004 Nov 19 |
3 |
| 721 |
12730697 | Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. | 2003 Jun |
2 |
| 722 |
27809434 | Cholesterol Lowering Drugs | 2000 |
2 |
| 723 |
28402615 | Triglyceride Lowering Drugs | 2000 |
1 |
| 724 |
7773731 | FH Afrikaner-3 LDL receptor mutation results in defective LDL receptors and causes a mild form of familial hypercholesterolemia. | 1995 Jun |
1 |